Industry: Medical Devices & Consumables
Published Date: 2024-08-21
Pages: 103 Pages
Report ld: 3286648
Request Sample
Customized Report
Class III Medical Imaging Software Market Size(US$)

CAGR 2024-2030
7.5%
Market Size,2030
USD 1,390
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Class III Medical Imaging Software refers to advanced AI-powered applications that are critical for diagnosing and managing life-threatening conditions. These software systems are designed to analyze medical images, such as CT scans, MRIs, and X-rays, with a high degree of accuracy, often providing diagnostic support or even making clinical decisions. Due to their role in critical healthcare scenarios, Class III AI medical imaging software is subject to rigorous regulatory oversight to ensure its safety, efficacy, and reliability in clinical practice.
The global market for Class III Medical Imaging Software was estimated to be worth US$ 842 million in 2023 and is forecast to a readjusted size of US$ 1390 million by 2030 with a CAGR of 7.5% during the forecast period 2024-2030.
North American market for Class III Medical Imaging Software was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Class III Medical Imaging Software was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Class III Medical Imaging Software was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Class III Medical Imaging Software include GE, Philips, IBM, Arterys, AZmed, Deepwise, Shukun Technology, Infervision Medical, United-Imaging, Yizhun Intelligent, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
The Class III Medical Imaging Software market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Class III Medical Imaging Software.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Class III Medical Imaging Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Class III Medical Imaging Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Class III Medical Imaging Software in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Class III Medical Imaging Software Product Introduction
1.2 Global Class III Medical Imaging Software Market Size Forecast (2019-2030)
1.3 Class III Medical Imaging Software Market Trends & Drivers
1.3.1 Class III Medical Imaging Software Industry Trends
1.3.2 Class III Medical Imaging Software Market Drivers & Opportunity
1.3.3 Class III Medical Imaging Software Market Challenges
1.3.4 Class III Medical Imaging Software Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Class III Medical Imaging Software Players Revenue Ranking (2023)
2.2 Global Class III Medical Imaging Software Revenue by Company (2019-2024)
2.3 Key Companies Class III Medical Imaging Software Manufacturing Base Distribution and Headquarters
2.4 Key Companies Class III Medical Imaging Software Product Offered
2.5 Key Companies Time to Begin Mass Production of Class III Medical Imaging Software
2.6 Class III Medical Imaging Software Market Competitive Analysis
2.6.1 Class III Medical Imaging Software Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Class III Medical Imaging Software Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Class III Medical Imaging Software as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cardiovascular
3.1.2 Pulmonary
3.1.3 Cerebral
3.1.4 Others
3.2 Global Class III Medical Imaging Software Sales Value by Type
3.2.1 Global Class III Medical Imaging Software Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Class III Medical Imaging Software Sales Value, by Type (2019-2030)
3.2.3 Global Class III Medical Imaging Software Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Class III Medical Imaging Software Sales Value by Application
4.2.1 Global Class III Medical Imaging Software Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Class III Medical Imaging Software Sales Value, by Application (2019-2030)
4.2.3 Global Class III Medical Imaging Software Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Class III Medical Imaging Software Sales Value by Region
5.1.1 Global Class III Medical Imaging Software Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Class III Medical Imaging Software Sales Value by Region (2019-2024)
5.1.3 Global Class III Medical Imaging Software Sales Value by Region (2025-2030)
5.1.4 Global Class III Medical Imaging Software Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Class III Medical Imaging Software Sales Value, 2019-2030
5.2.2 North America Class III Medical Imaging Software Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Class III Medical Imaging Software Sales Value, 2019-2030
5.3.2 Europe Class III Medical Imaging Software Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Class III Medical Imaging Software Sales Value, 2019-2030
5.4.2 Asia Pacific Class III Medical Imaging Software Sales Value by Region (%), 2023 VS 2030
5.5 South America
5.5.1 South America Class III Medical Imaging Software Sales Value, 2019-2030
5.5.2 South America Class III Medical Imaging Software Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Class III Medical Imaging Software Sales Value, 2019-2030
5.6.2 Middle East & Africa Class III Medical Imaging Software Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Class III Medical Imaging Software Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Class III Medical Imaging Software Sales Value, 2019-2030
6.3 United States
6.3.1 United States Class III Medical Imaging Software Sales Value, 2019-2030
6.3.2 United States Class III Medical Imaging Software Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Class III Medical Imaging Software Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Class III Medical Imaging Software Sales Value, 2019-2030
6.4.2 Europe Class III Medical Imaging Software Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Class III Medical Imaging Software Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Class III Medical Imaging Software Sales Value, 2019-2030
6.5.2 China Class III Medical Imaging Software Sales Value by Type (%), 2023 VS 2030
6.5.3 China Class III Medical Imaging Software Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Class III Medical Imaging Software Sales Value, 2019-2030
6.6.2 Japan Class III Medical Imaging Software Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Class III Medical Imaging Software Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Class III Medical Imaging Software Sales Value, 2019-2030
6.7.2 South Korea Class III Medical Imaging Software Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Class III Medical Imaging Software Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Class III Medical Imaging Software Sales Value, 2019-2030
6.8.2 Southeast Asia Class III Medical Imaging Software Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Class III Medical Imaging Software Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Class III Medical Imaging Software Sales Value, 2019-2030
6.9.2 India Class III Medical Imaging Software Sales Value by Type (%), 2023 VS 2030
6.9.3 India Class III Medical Imaging Software Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GE
7.1.1 GE Profile
7.1.2 GE Main Business
7.1.3 GE Class III Medical Imaging Software Products, Services and Solutions
7.1.4 GE Class III Medical Imaging Software Revenue (US$ Million) & (2019-2024)
7.1.5 GE Recent Developments
7.2 Philips
7.2.1 Philips Profile
7.2.2 Philips Main Business
7.2.3 Philips Class III Medical Imaging Software Products, Services and Solutions
7.2.4 Philips Class III Medical Imaging Software Revenue (US$ Million) & (2019-2024)
7.2.5 Philips Recent Developments
7.3 IBM
7.3.1 IBM Profile
7.3.2 IBM Main Business
7.3.3 IBM Class III Medical Imaging Software Products, Services and Solutions
7.3.4 IBM Class III Medical Imaging Software Revenue (US$ Million) & (2019-2024)
7.3.5 IBM Recent Developments
7.4 Arterys
7.4.1 Arterys Profile
7.4.2 Arterys Main Business
7.4.3 Arterys Class III Medical Imaging Software Products, Services and Solutions
7.4.4 Arterys Class III Medical Imaging Software Revenue (US$ Million) & (2019-2024)
7.4.5 Arterys Recent Developments
7.5 AZmed
7.5.1 AZmed Profile
7.5.2 AZmed Main Business
7.5.3 AZmed Class III Medical Imaging Software Products, Services and Solutions
7.5.4 AZmed Class III Medical Imaging Software Revenue (US$ Million) & (2019-2024)
7.5.5 AZmed Recent Developments
7.6 Deepwise
7.6.1 Deepwise Profile
7.6.2 Deepwise Main Business
7.6.3 Deepwise Class III Medical Imaging Software Products, Services and Solutions
7.6.4 Deepwise Class III Medical Imaging Software Revenue (US$ Million) & (2019-2024)
7.6.5 Deepwise Recent Developments
7.7 Shukun Technology
7.7.1 Shukun Technology Profile
7.7.2 Shukun Technology Main Business
7.7.3 Shukun Technology Class III Medical Imaging Software Products, Services and Solutions
7.7.4 Shukun Technology Class III Medical Imaging Software Revenue (US$ Million) & (2019-2024)
7.7.5 Shukun Technology Recent Developments
7.8 Infervision Medical
7.8.1 Infervision Medical Profile
7.8.2 Infervision Medical Main Business
7.8.3 Infervision Medical Class III Medical Imaging Software Products, Services and Solutions
7.8.4 Infervision Medical Class III Medical Imaging Software Revenue (US$ Million) & (2019-2024)
7.8.5 Infervision Medical Recent Developments
7.9 United-Imaging
7.9.1 United-Imaging Profile
7.9.2 United-Imaging Main Business
7.9.3 United-Imaging Class III Medical Imaging Software Products, Services and Solutions
7.9.4 United-Imaging Class III Medical Imaging Software Revenue (US$ Million) & (2019-2024)
7.9.5 United-Imaging Recent Developments
7.10 Yizhun Intelligent
7.10.1 Yizhun Intelligent Profile
7.10.2 Yizhun Intelligent Main Business
7.10.3 Yizhun Intelligent Class III Medical Imaging Software Products, Services and Solutions
7.10.4 Yizhun Intelligent Class III Medical Imaging Software Revenue (US$ Million) & (2019-2024)
7.10.5 Yizhun Intelligent Recent Developments
7.11 Siemens
7.11.1 Siemens Profile
7.11.2 Siemens Main Business
7.11.3 Siemens Class III Medical Imaging Software Products, Services and Solutions
7.11.4 Siemens Class III Medical Imaging Software Revenue (US$ Million) & (2019-2024)
7.11.5 Siemens Recent Developments
7.12 Lepu Medical
7.12.1 Lepu Medical Profile
7.12.2 Lepu Medical Main Business
7.12.3 Lepu Medical Class III Medical Imaging Software Products, Services and Solutions
7.12.4 Lepu Medical Class III Medical Imaging Software Revenue (US$ Million) & (2019-2024)
7.12.5 Lepu Medical Recent Developments
7.13 Pulse Medical
7.13.1 Pulse Medical Profile
7.13.2 Pulse Medical Main Business
7.13.3 Pulse Medical Class III Medical Imaging Software Products, Services and Solutions
7.13.4 Pulse Medical Class III Medical Imaging Software Revenue (US$ Million) & (2019-2024)
7.13.5 Pulse Medical Recent Developments
8 Industry Chain Analysis
8.1 Class III Medical Imaging Software Industrial Chain
8.2 Class III Medical Imaging Software Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Class III Medical Imaging Software Sales Model
8.5.2 Sales Channel
8.5.3 Class III Medical Imaging Software Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Class III Medical Imaging Software market is projected to grow from US$ 964 million in 2025 to US$ 1583 million by 2032, at a CAGR of 7.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 144
USD 4900.00
(Single User License)
The global Class III Medical Imaging Software market size was US$ 964 million in 2025 and is forecast to reach a readjusted size of US$ 1583 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 91
USD 4250.00
(Single User License)
The global Class III Medical Imaging Software market was valued at US$ 964 million in 2025 and is anticipated to reach US$ 1583 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 119
USD 2900.00
(Single User License)
The global market for Class III Medical Imaging Software was estimated to be worth US$ 964 million in 2025 and is projected to reach US$ 1583 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 106
USD 3950.00
(Single User License)
The global Class III Medical Imaging Software market is projected to grow from US$ 903 million in 2024 to US$ 1484 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 134
USD 4900.00
(Single User License)
The global Class III Medical Imaging Software market size was US$ 903 million in 2024 and is forecast to a readjusted size of US$ 1484 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 94
USD 4250.00
(Single User License)
The global market for Class III Medical Imaging Software was estimated to be worth US$ 903 million in 2024 and is forecast to a readjusted size of US$ 1484 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 112
USD 3950.00
(Single User License)
The global market for Class III Medical Imaging Software was valued at US$ 903 million in the year 2024 and is projected to reach a revised size of US$ 1484 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published Date: 2025-03-10
Pages: 82
USD 2900.00
(Single User License)
Class III Medical Imaging Software refers to advanced AI-powered applications that are critical for diagnosing and managing life-threatening conditions. These software systems are designed to analyze medical images, such as CT scans, MRIs, and X-rays, with a high degree of accuracy, often providing diagnostic support or even making clinical decisions. Due to their role in critical healthcare scenarios, Class III AI medical imaging software is subject to rigorous regulatory oversight to ensure its safety, efficacy, and reliability in clinical practice.
Published Date: 2024-08-21
Pages: 112
USD 4350.00
(Single User License)
Class III Medical Imaging Software refers to advanced AI-powered applications that are critical for diagnosing and managing life-threatening conditions. These software systems are designed to analyze medical images, such as CT scans, MRIs, and X-rays, with a high degree of accuracy, often providing diagnostic support or even making clinical decisions. Due to their role in critical healthcare scenarios, Class III AI medical imaging software is subject to rigorous regulatory oversight to ensure its safety, efficacy, and reliability in clinical practice.
Published Date: 2024-08-21
Pages: 136
USD 4900.00
(Single User License)
The global Class III Medical Imaging Software market is projected to grow from US$ 964 million in 2025 to US$ 1583 million by 2032, at a CAGR of 7.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 144
The global Class III Medical Imaging Software market size was US$ 964 million in 2025 and is forecast to reach a readjusted size of US$ 1583 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 91
The global Class III Medical Imaging Software market was valued at US$ 964 million in 2025 and is anticipated to reach US$ 1583 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-01-09
Pages: 119
The global market for Class III Medical Imaging Software was estimated to be worth US$ 964 million in 2025 and is projected to reach US$ 1583 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-01-09
Pages: 106
The global Class III Medical Imaging Software market is projected to grow from US$ 903 million in 2024 to US$ 1484 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 134
The global Class III Medical Imaging Software market size was US$ 903 million in 2024 and is forecast to a readjusted size of US$ 1484 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 94
The global market for Class III Medical Imaging Software was estimated to be worth US$ 903 million in 2024 and is forecast to a readjusted size of US$ 1484 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 112
The global market for Class III Medical Imaging Software was valued at US$ 903 million in the year 2024 and is projected to reach a revised size of US$ 1484 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published: 2025-03-10
Pages: 82
Class III Medical Imaging Software refers to advanced AI-powered applications that are critical for diagnosing and managing life-threatening conditions. These software systems are designed to analyze medical images, such as CT scans, MRIs, and X-rays, with a high degree of accuracy, often providing diagnostic support or even making clinical decisions. Due to their role in critical healthcare scenarios, Class III AI medical imaging software is subject to rigorous regulatory oversight to ensure its safety, efficacy, and reliability in clinical practice.
Published: 2024-08-21
Pages: 112
Class III Medical Imaging Software refers to advanced AI-powered applications that are critical for diagnosing and managing life-threatening conditions. These software systems are designed to analyze medical images, such as CT scans, MRIs, and X-rays, with a high degree of accuracy, often providing diagnostic support or even making clinical decisions. Due to their role in critical healthcare scenarios, Class III AI medical imaging software is subject to rigorous regulatory oversight to ensure its safety, efficacy, and reliability in clinical practice.
Published: 2024-08-21
Pages: 136
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now